Kezar Life Sciences Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$7.29

-0.07 (-0.95%)

As of May 16, 2:21 AM ET ·

Analyst Consensus

Hold

Analysts

Moderate

Coverage

Buy 4 44%

Hold 5 56%

Sell 0 0%

Price Target

Analyst Price Target +158.0% upside

Low Target $12.87

Average Target $18.81

High Target $22.25

Current Price $7.29

Current
$7.29

Target
$18.81

$12.87 $18.81 avg $22.25

Scenario Analysis

Bear Case

$12.87

76.5%

Low target

Base Case

$18.81

+158.0%

Avg target

Bull Case

$22.25

+205.2%

High target

Risk/Reward

2.7x

Favorable

Price in Context

52-Week High

$7.55

-3.4% from high

52-Week Low

$3.53

+106.5% from low

Target vs 52W High

$18.81

+149.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%